Cargando…

miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway

Acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib, is a critical issue for the treatment of EGFR mutant-positive non-small cell lung cancer (NSCLC). Recent evidence supports the role of microRNA-223 (miR-223) in modulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	HAN, JING, ZHAO, FENGYI, ZHANG, JING, ZHU, HAIZHEN, MA, HU, LI, XUETAO, PENG, LINA, SUN, JIANGUO, CHEN, ZHENGTANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809653/ https://www.ncbi.nlm.nih.gov/pubmed/26936292 http://dx.doi.org/10.3892/ijo.2016.3401

Ejemplares similares

miR-181b-5p mediates TGF-β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells
por: Li, Xuetao, et al.
Publicado: (2017)

MiR-223 Suppresses Cell Proliferation by Targeting IGF-1R
por: Jia, Cheng You, et al.
Publicado: (2011)

miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways
por: Sun, Xiaoyan, et al.
Publicado: (2016)

MiR-223 Regulates Human Embryonic Stem Cell Differentiation by Targeting the IGF-1R/Akt Signaling Pathway
por: Yu, Yan-Hui, et al.
Publicado: (2013)

Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway
por: Pan, Yong-hong, et al.
Publicado: (2018)

Down-Regulation of MicroRNA-223 Promotes Degranulation via the PI3K/Akt Pathway by Targeting IGF-1R in Mast Cells
por: Wang, Quan, et al.
Publicado: (2015)

Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer
por: Zhou, Juan, et al.
Publicado: (2015)

Bufalin Reverses HGF-Induced Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer Cells via Blockage of Met/PI3k/Akt Pathway and Induction of Apoptosis
por: Kang, Xiao-Hong, et al.
Publicado: (2013)

MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young Adults
por: Casanova, Michela, et al.
Publicado: (2022)

Naringenin promotes angiogenesis of ischemic myocardium after myocardial infarction through miR-223-3p/IGF1R axis
por: Fu, Jinguo, et al.
Publicado: (2022)

Potential role of miR-9 and miR-223 in recurrent ovarian cancer
por: Laios, Alexandros, et al.
Publicado: (2008)

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
por: Wen, Miaomiao, et al.
Publicado: (2018)

MiR-200c overexpression is associated with better efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild-type
por: Li, Jiayu, et al.
Publicado: (2014)

MiR-223 regulates the differentiation of immature neurons
por: Harraz, Maged M, et al.
Publicado: (2014)

Role of miR-223 in the pathophysiology of liver diseases
por: Ye, Dan, et al.
Publicado: (2018)

miR-223: An Immune Regulator in Infectious Disorders
por: Yuan, Shun, et al.
Publicado: (2021)

Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
por: Wei, Zhigang, et al.
Publicado: (2017)

miR-181d promotes cell proliferation via the IGF1/PI3K/AKT axis in glioma
por: Tang, Dong, et al.
Publicado: (2020)

miR-365 inhibits duck myoblast proliferation by targeting IGF-I via PI3K/Akt pathway
por: Sun, Wenqiang, et al.
Publicado: (2019)

Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors
por: Hellberg, Teresa, et al.
Publicado: (2020)

Plasma miR-153 and miR-223 Levels as Potential Biomarkers in Parkinson’s Disease
por: Wu, Li, et al.
Publicado: (2022)

Concomitant Mutations in EGFR 19Del/L858R Mutation and Their Association with Response to EGFR-TKIs in NSCLC Patients
por: Liang, Hengrui, et al.
Publicado: (2020)

Combination therapy of brain radiotherapy and EGFR-TKIs is more effective than TKIs alone for EGFR-mutant lung adenocarcinoma patients with asymptomatic brain metastasis
por: Chen, Yanxin, et al.
Publicado: (2019)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-223 expressions: a study on postmenopausal monozygotic twin pairs
por: Olivieri, Fabiola, et al.
Publicado: (2014)

Bta-miR-223 Targeting CBLB Contributes to Resistance to Staphylococcus aureus Mastitis Through the PI3K/AKT/NF-κB Pathway
por: Han, Shuo, et al.
Publicado: (2020)

Decoy Oligonucleotide Rescues IGF1R Expression from MicroRNA-223 Suppression
por: Wu, Li Hui, et al.
Publicado: (2013)

The protective role of miR-223 in sepsis-induced mortality
por: Liu, Dan, et al.
Publicado: (2020)

In vivo targeting of miR‐223 in experimental eosinophilic oesophagitis
por: Collison, Adam M, et al.
Publicado: (2020)

Identification of MiR-223 Associated with Diagnosis in Ectopic Pregnancy
por: Qiu, Jiahan, et al.
Publicado: (2023)

miR-223: a key regulator of pulmonary inflammation
por: Shi, Mingyu, et al.
Publicado: (2023)

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
por: Fourdinier, Ophélie, et al.
Publicado: (2019)

MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction
por: Elbaz, Meyer, et al.
Publicado: (2022)

CircRILPL1 promotes muscle proliferation and differentiation via binding miR-145 to activate IGF1R/PI3K/AKT pathway
por: Shen, Xuemei, et al.
Publicado: (2021)

Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
por: Ma, Jia, et al.
Publicado: (2015)

Hypoxic TAM-derived exosomal miR-155-5p promotes RCC progression through HuR-dependent IGF1R/AKT/PI3K pathway
por: Gu, Wenyu, et al.
Publicado: (2021)

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
por: Gallardo, A, et al.
Publicado: (2012)

miR-9-5p Inhibits Skeletal Muscle Satellite Cell Proliferation and Differentiation by Targeting IGF2BP3 through the IGF2-PI3K/Akt Signaling Pathway
por: Yin, Huadong, et al.
Publicado: (2020)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients
por: Yan, Han, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j1o8lp7h1pskv228g1i73t7lt2